ARGUS II RETINAL PROSTHESIS 011014-007-K 011014

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,s report with the FDA on 2016-07-27 for ARGUS II RETINAL PROSTHESIS 011014-007-K 011014 manufactured by Second Sight Medical Products, Inc..

Event Text Entries

[50575927] All pertinent information available to second sight medical products, inc. Has been submitted. The company is submitting this mdr to ensure full compliance with 21 cfr part 803.
Patient Sequence No: 1, Text Type: N, H10


[50575928] This patient was implanted with an argus ii device on (b)(6) 2015 as part of a clinical trial for amd subjects. On (b)(6) 2016, the patient reported experiencing blurry vision and discomfort in the implanted eye. On (b)(6) 2016, patient's was diagnosed with hypotony (intraocular pressure was 5 mmhg) and inflammation, and was prescribed steroids and antibiotic topical treatments. On (b)(6) 2016, a surgical intervention was conducted during which intravitreal gas was injected into the eye. On (b)(6) 2016, a second revision surgery was conducted during which the sclerotomy was re-sutured, the scleral patch graft was replaced, and an air bubble was injected. Following the surgery, the surgeon reported that the patient's intraocular pressure in the implanted eye has remained stable at 10 mmhg. There was no defect or malfunction of the device associated with this event.
Patient Sequence No: 1, Text Type: D, B5


[54345379] This event represents a follow-up report to mdr# 3004081696-2016-00011. All pertinent information available to second sight medical products, inc. Has been submitted. The company is submitting this mdr to ensure full compliance with 21 cfr part 803.
Patient Sequence No: 1, Text Type: N, H10


[54345380] This patient experienced hypotony in the implanted eye, and underwent two revision surgeries on (b)(6) 2016, respectively. New information: on (b)(6) 2016, it was reported that the patient's intraocular pressure (iop) had been 8-10 mmhg in the 2 weeks following the second revision surgery conducted on (b)(6) 2016. On (b)(6) 2016, a third revision surgery was conducted during which a vitrectomy and silicone oil injection was performed. On (b)(6) 2016, the patient's iop was 12 mmhg and the surgeon reported a marked improvement with no inflammation. The patient's retina was fully attached and the implant was in place.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3004081696-2016-00011
MDR Report Key5826756
Report SourceFOREIGN,HEALTH PROFESSIONAL,S
Date Received2016-07-27
Date of Report2016-06-27
Date of Event2016-06-27
Date Mfgr Received2016-06-27
Device Manufacturer Date2014-11-06
Date Added to Maude2016-07-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. MARK LOAR
Manufacturer Street12744 SAN FERNANDO RD. SUITE 400
Manufacturer CitySYLMAR CA 91342
Manufacturer CountryUS
Manufacturer Postal91342
Manufacturer Phone8188335049
Manufacturer G1SECOND SIGHT MEDICAL PRODUCTS, INC.
Manufacturer Street12744 SAN FERNANDO RD. SUITE 400
Manufacturer CitySYLMAR CA 91342
Manufacturer CountryUS
Manufacturer Postal Code91342
Single Use3
Previous Use Code3
Removal Correction NumberN/A
Event Type3
Type of Report3

Device Details

Brand NameARGUS II RETINAL PROSTHESIS
Generic NameRETINAL PROSTHESIS
Product CodeNBF
Date Received2016-07-27
Model Number011014-007-K
Catalog Number011014
Lot NumberN/A
Device Expiration Date2016-11-06
OperatorPHYSICIAN
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSECOND SIGHT MEDICAL PRODUCTS, INC.
Manufacturer Address12744 SAN FERNANDO RD. SUITE 400 SYLMAR CA 91342 US 91342


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2016-07-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.